Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

XBI vs. FBTAX: which is better?

Bottom line

XBI vs FBTAX: the short answer

XBI (State Street(R) SPDR(R) S&P(R) Biotech ETF) and FBTAX (Fidelity Advisor Biotechnology Fund) are quite different portfolios: only about 21% of their top holdings (by weight) are shared.

XBI is cheaper at 0.35% vs 0.94% — a difference of $59 a year per $10,000 invested.

Over five years, FBTAX returned +6.4% a year vs −2.7% for XBI (reporting dates differ).

Updated Nov 19, 2026

XBI vs FBTAX side by side

XBIFBTAX
TypeETFMutual fund
Fund familySPDR (State Street)Fidelity
CategoryTechnology SectorTechnology Sector
Expense ratio0.35%0.94%
Annual cost per $10k$35$94
10-yr cost on $10k (prospectus)$443$1,663
Max front loadNone—
12b-1 fee0%0.25%
1-yr return+35.8%+31.5%
5-yr return (annualized)−2.7%+6.4%
10-yr return (annualized)+5.8%+7.7%
Best quarter+44.4%+30.3%
Worst quarter−26.2%−27.8%
Net assets (fund)$10.7B$2.2B
Number of holdings161129
Portfolio turnover71%54%
Returns as ofDec 31, 2025Sep 30, 2026

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearXBIFBTAXDifference
2025+35.8%+39.6%−3.7%
2024+1.1%+5.3%−4.2%
2023+7.5%+10.7%−3.2%
2022−25.8%−8.0%−17.8%
2021−20.5%−3.6%−17.0%
2020+48.2%+32.2%+16.0%
2019+32.2%+25.7%+6.5%
2018−14.9%−3.8%−11.1%
2017+43.7%+25.8%+17.9%
2016−15.4%−23.6%+8.2%

Source: Fund prospectus bar charts

Holdings overlap

7 of XBI's top 25 holdings also appear in FBTAX's top 25.

Shared top holdings
HoldingXBIFBTAX
Moderna Inc1.41%1.60%
Oruka Therapeutics Inc1.38%3.24%
Revolution Medicines Inc1.20%3.00%
Vaxcyte Inc1.19%1.97%
Dianthus Therapeutics Inc1.18%3.55%
Natera Inc1.16%1.43%
Cogent Biosciences Inc1.14%3.25%

Source: SEC Form N-PORT

XBI top 10

  1. State Street Global Advisors — 5.87%
  2. Apogee Therapeutics Inc — 1.49%
  3. Moderna Inc — 1.41%
  4. Twist Bioscience Corp — 1.41%
  5. Oruka Therapeutics Inc — 1.38%
  6. Kymera Therapeutics Inc — 1.36%
  7. Viking Therapeutics Inc — 1.30%
  8. Praxis Precision Medicines Inc — 1.29%
  9. Erasca Inc — 1.27%
  10. Revolution Medicines Inc — 1.20%

FBTAX top 10

  1. Abbvie Inc — 14.71%
  2. Gilead Sciences Inc — 5.70%
  3. Spyre Therapeutics Inc — 3.83%
  4. Alnylam Pharmaceuticals Inc — 3.62%
  5. Dianthus Therapeutics Inc — 3.55%
  6. Cogent Biosciences Inc — 3.25%
  7. Oruka Therapeutics Inc — 3.24%
  8. Insmed Inc — 3.05%
  9. Revolution Medicines Inc — 3.00%
  10. Argenx Se — 3.00%

FAQ

What is the difference between XBI and FBTAX?
XBI (State Street(R) SPDR(R) S&P(R) Biotech ETF) and FBTAX (Fidelity Advisor Biotechnology Fund) are quite different portfolios: only about 21% of their top holdings (by weight) are shared. XBI is cheaper at 0.35% vs 0.94% — a difference of $59 a year per $10,000 invested.
Which is cheaper, XBI or FBTAX?
XBI has the lower expense ratio (0.35%).
Should I own both XBI and FBTAX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.